Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to GT199200068ApriorityCriticalpatent/GT199200068A/en
Publication of GT199200068ApublicationCriticalpatent/GT199200068A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO DE OBTENCION DE SULFONAMIDAS DE ESTRUCTURA QUIMICA I CONTENIDA EN LA FICHA TECNICA RESPECTIVA. Y LAS SALES DE LAS MISMAS, PUEDEN SER UTILIZADAS COMO INGREDIENTES ACTIVOS PARA LA ELABORACION DE MEDICAMENTOS PARA EN TRATAMIENTO DE TRASTORNOS CIRCULATORIOS, ESPECIELMENTELA HIPERTENSION, ISQUEMIA, VASOSPASMOS, ANGINA PECTORIS.IT REFERS TO A PROCEDURE FOR OBTAINING SULFONAMIDES OF CHEMICAL STRUCTURE I CONTAINED IN THE RESPECTIVE TECHNICAL SHEET. AND THE SALTS OF THE SAME, CAN BE USED AS ACTIVE INGREDIENTS FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF CIRCULATORY DISORDERS, ESPECIALLY THE HYPERTENSION, ISCHEMIA, VASOSPASMS, ANGINA PECTORIS.
Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a drug useful in the treatment of social anxiety (divisional application 1799-00).